Glenmark Life Sciences Limited (GLS.BO)
INR 1085.8
(0.0%)
INR 1085.8
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 11.64 Billion INR | 58.85% |
| 2022 | 4.15 Billion INR | -7.78% |
| 2021 | 4.5 Billion INR | 17.41% |
| 2020 | 3.83 Billion INR | 10.38% |
| 2019 | 3.47 Billion INR | 7.8% |
| 2018 | 3.22 Billion INR | 1344620.83% |
| 2017 | 240 Thousand INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.62 Billion INR | 0.46% |
| 2024 Q1 | 844.98 Million INR | -50.58% |
| 2023 Q1 | 1.49 Billion INR | 910.26% |
| 2023 FY | 6.6 Billion INR | 58.85% |
| 2023 Q3 | 1.71 Billion INR | 1.73% |
| 2023 Q2 | 1.68 Billion INR | 12.32% |
| 2023 Q4 | 1.7 Billion INR | -0.14% |
| 2022 Q1 | 1.24 Billion INR | 65.54% |
| 2022 FY | 4.15 Billion INR | -7.78% |
| 2022 Q4 | 148.34 Million INR | -89.49% |
| 2022 Q3 | 1.41 Billion INR | 4.12% |
| 2022 Q2 | 1.35 Billion INR | 9.3% |
| 2021 Q1 | 1.13 Billion INR | 51.53% |
| 2021 Q2 | 1.32 Billion INR | 16.56% |
| 2021 Q3 | 1.29 Billion INR | -2.91% |
| 2021 Q4 | 749.54 Million INR | -41.9% |
| 2021 FY | 4.5 Billion INR | 17.41% |
| 2020 FY | 3.83 Billion INR | 10.38% |
| 2020 Q4 | 752.31 Million INR | -31.7% |
| 2020 Q3 | 1.1 Billion INR | 1.74% |
| 2020 Q2 | 1.08 Billion INR | 19.94% |
| 2020 Q1 | 902.6 Million INR | 0.0% |
| 2019 FY | 3.47 Billion INR | 7.8% |
| 2018 FY | 3.22 Billion INR | 1344620.83% |
| 2017 FY | 240 Thousand INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 26.648% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 70.331% |
| Granules India Limited | 7.18 Billion INR | -62.073% |
| Indoco Remedies Limited | 4.74 Billion INR | -145.131% |
| Achyut Healthcare Limited | 1.6 Million INR | -723373.586% |
| Ajanta Pharma Limited | 30.46 Billion INR | 61.787% |
| Alkem Laboratories Limited | 32.83 Billion INR | 64.548% |
| Alpa Laboratories Limited | 156.14 Million INR | -7354.956% |
| Brooks Laboratories Limited | 51.18 Million INR | -22644.607% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -347.65% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1081.382% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -720.216% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 87.859% |
| Eris Lifesciences Limited | 4.94 Billion INR | -135.501% |
| FDC Limited | 5.34 Billion INR | -117.643% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 82.771% |
| Gufic Biosciences Limited | 1.07 Billion INR | -980.131% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -448.008% |
| Ipca Laboratories Limited | 13.91 Billion INR | 16.344% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -1405.112% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -25120.318% |
| Lasa Supergenerics Limited | 291.17 Million INR | -3897.847% |
| Laurus Labs Limited | 3.01 Billion INR | -286.631% |
| Lupin Limited | 95.67 Billion INR | 87.833% |
| Mankind Pharma Limited | 23.15 Billion INR | 49.722% |
| Medicamen Biotech Limited | 335.16 Million INR | -3373.101% |
| Medico Remedies Limited | 161.84 Million INR | -7092.537% |
| Megasoft Limited | 49.52 Million INR | -23403.251% |
| NATCO Pharma Limited | 10.05 Billion INR | -15.736% |
| Piramal Pharma Limited | 19.91 Billion INR | 41.545% |
| RPG Life Sciences Limited | 1.63 Billion INR | -611.751% |
| Sigachi Industries Limited | 579.88 Million INR | -1907.407% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 92.45% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -729.825% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -1135.219% |
| Unichem Laboratories Limited | 6.72 Billion INR | -73.073% |
| Wanbury Limited | 1.16 Billion INR | -902.706% |
| Windlas Biotech Limited | 1 Billion INR | -1056.54% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1049.065% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 73.038% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -278.338% |
| Divi's Laboratories Limited | 14.17 Billion INR | 17.85% |
| Hester Biosciences Limited | 908.84 Million INR | -1180.829% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -288.619% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -959.219% |
| Bal Pharma Limited | 389.89 Million INR | -2885.634% |
| Strides Pharma Science Limited | 9.16 Billion INR | -27.05% |
| Venus Remedies Limited | 1.91 Billion INR | -507.462% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -278.633% |
| Nectar Lifesciences Limited | 625.55 Million INR | -1760.873% |
| Shilpa Medicare Limited | 2.18 Billion INR | -433.832% |
| Aarti Drugs Limited | 1.16 Billion INR | -897.079% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -959.4% |
| Suven Life Sciences Limited | 109.75 Million INR | -10506.551% |
| Ind-Swift Limited | 946.56 Million INR | -1129.78% |
| Valiant Laboratories Limited | 36.28 Million INR | -31977.737% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | -38.298% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | -154.18% |
| Themis Medicare Limited | 782.85 Million INR | -1386.954% |
| Hikal Limited | 2.48 Billion INR | -368.186% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 45.66% |
| Sequent Scientific Limited | 2.9 Billion INR | -301.153% |
| Novartis India Limited | 470.1 Million INR | -2376.216% |
| Wockhardt Limited | 6.4 Billion INR | -81.886% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 19.464% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -71713.116% |
| Neuland Laboratories Limited | 2.92 Billion INR | -297.328% |
| Morepen Laboratories Limited | 1.98 Billion INR | -485.71% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -2722.485% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -1621.621% |